Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-26

FDA Approved: GABAPENTIN — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approval of Gabapentin in an original application for Camber Pharmaceuticals, establishing a generic version of Gabapentin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)